The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nucleic Acid Multiplex Assay-Global Market Insights and Sales Trends 2024
Synopsis
The global Nucleic Acid Multiplex Assay market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nucleic Acid Multiplex Assay in various end use industries. The expanding demands from the Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Other, are propelling Nucleic Acid Multiplex Assay market. Planar Nucleic Acid Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bead-Based Nucleic Acid Assays segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nucleic Acid Multiplex Assay market, driven by demand from China, the second largest economy with some signs of stabilising, the Nucleic Acid Multiplex Assay market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nucleic Acid Multiplex Assay, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nucleic Acid Multiplex Assay market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nucleic Acid Multiplex Assay market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nucleic Acid Multiplex Assay sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nucleic Acid Multiplex Assay covered in this report include Luminex Corporation (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc (US), Bio-Rad Laboratories, Inc. (US), Qiagen N.V. (Netherlands), Abcam plc (UK), Becton, Dickinson and Company (US), Merck KGaA (Germany) and Agilent Technologies, Inc. (US), etc.
The global Nucleic Acid Multiplex Assay market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Luminex Corporation (US)
Thermo Fisher Scientific Inc. (US)
Illumina, Inc (US)
Bio-Rad Laboratories, Inc. (US)
Qiagen N.V. (Netherlands)
Abcam plc (UK)
Becton, Dickinson and Company (US)
Merck KGaA (Germany)
Agilent Technologies, Inc. (US)
Meso Scale Diagnostics (US)
Randox Laboratories (UK)
Quanterix (US)
Bio-Techne Corporation (US)
Olink (Sweden)
DiaSorin S.p.A. (Italy)
Seegene (South Korea)
Promega Corporation (US)
Siemens Healthineers (Germany)
PerkinElmer, Inc. (US)
Shimadzu Biotech (Japan)
Antigenix America, Inc. (US)
Enzo Life Sciences, Inc. (US)
Boster Biological Technology (US)
AYOXXA Biosystems GmbH (Germany)
Cayman Chemical Company (US)
Global Nucleic Acid Multiplex Assay market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nucleic Acid Multiplex Assay market, Segment by Type:
Planar Nucleic Acid Assays
Bead-Based Nucleic Acid Assays
Other Nucleic Acid Assays
Global Nucleic Acid Multiplex Assay market, by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nucleic Acid Multiplex Assay companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Nucleic Acid Multiplex Assay market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nucleic Acid Multiplex Assay in various end use industries. The expanding demands from the Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Other, are propelling Nucleic Acid Multiplex Assay market. Planar Nucleic Acid Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bead-Based Nucleic Acid Assays segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nucleic Acid Multiplex Assay market, driven by demand from China, the second largest economy with some signs of stabilising, the Nucleic Acid Multiplex Assay market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nucleic Acid Multiplex Assay, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nucleic Acid Multiplex Assay market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nucleic Acid Multiplex Assay market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nucleic Acid Multiplex Assay sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nucleic Acid Multiplex Assay covered in this report include Luminex Corporation (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc (US), Bio-Rad Laboratories, Inc. (US), Qiagen N.V. (Netherlands), Abcam plc (UK), Becton, Dickinson and Company (US), Merck KGaA (Germany) and Agilent Technologies, Inc. (US), etc.
The global Nucleic Acid Multiplex Assay market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Luminex Corporation (US)
Thermo Fisher Scientific Inc. (US)
Illumina, Inc (US)
Bio-Rad Laboratories, Inc. (US)
Qiagen N.V. (Netherlands)
Abcam plc (UK)
Becton, Dickinson and Company (US)
Merck KGaA (Germany)
Agilent Technologies, Inc. (US)
Meso Scale Diagnostics (US)
Randox Laboratories (UK)
Quanterix (US)
Bio-Techne Corporation (US)
Olink (Sweden)
DiaSorin S.p.A. (Italy)
Seegene (South Korea)
Promega Corporation (US)
Siemens Healthineers (Germany)
PerkinElmer, Inc. (US)
Shimadzu Biotech (Japan)
Antigenix America, Inc. (US)
Enzo Life Sciences, Inc. (US)
Boster Biological Technology (US)
AYOXXA Biosystems GmbH (Germany)
Cayman Chemical Company (US)
Global Nucleic Acid Multiplex Assay market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nucleic Acid Multiplex Assay market, Segment by Type:
Planar Nucleic Acid Assays
Bead-Based Nucleic Acid Assays
Other Nucleic Acid Assays
Global Nucleic Acid Multiplex Assay market, by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nucleic Acid Multiplex Assay companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nucleic Acid Multiplex Assay
1.1 Nucleic Acid Multiplex Assay Market Overview
1.1.1 Nucleic Acid Multiplex Assay Product Scope
1.1.2 Nucleic Acid Multiplex Assay Market Status and Outlook
1.2 Global Nucleic Acid Multiplex Assay Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nucleic Acid Multiplex Assay Market Size by Region (2018-2029)
1.4 Global Nucleic Acid Multiplex Assay Historic Market Size by Region (2018-2023)
1.5 Global Nucleic Acid Multiplex Assay Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nucleic Acid Multiplex Assay Market Size (2018-2029)
1.6.1 North America Nucleic Acid Multiplex Assay Market Size (2018-2029)
1.6.2 Europe Nucleic Acid Multiplex Assay Market Size (2018-2029)
1.6.3 Asia-Pacific Nucleic Acid Multiplex Assay Market Size (2018-2029)
1.6.4 Latin America Nucleic Acid Multiplex Assay Market Size (2018-2029)
1.6.5 Middle East & Africa Nucleic Acid Multiplex Assay Market Size (2018-2029)
2 Nucleic Acid Multiplex Assay Market by Type
2.1 Introduction
2.1.1 Planar Nucleic Acid Assays
2.1.2 Bead-Based Nucleic Acid Assays
2.1.3 Other Nucleic Acid Assays
2.2 Global Nucleic Acid Multiplex Assay Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nucleic Acid Multiplex Assay Historic Market Size by Type (2018-2023)
2.2.2 Global Nucleic Acid Multiplex Assay Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nucleic Acid Multiplex Assay Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nucleic Acid Multiplex Assay Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nucleic Acid Multiplex Assay Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nucleic Acid Multiplex Assay Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nucleic Acid Multiplex Assay Revenue Breakdown by Type (2018-2029)
3 Nucleic Acid Multiplex Assay Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical & Biotechnology Companies
3.1.2 Hospitals & Research Institutes
3.1.3 Reference Laboratories
3.1.4 Other
3.2 Global Nucleic Acid Multiplex Assay Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nucleic Acid Multiplex Assay Historic Market Size by Application (2018-2023)
3.2.2 Global Nucleic Acid Multiplex Assay Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nucleic Acid Multiplex Assay Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nucleic Acid Multiplex Assay Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nucleic Acid Multiplex Assay Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nucleic Acid Multiplex Assay Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nucleic Acid Multiplex Assay Revenue Breakdown by Application (2018-2029)
4 Nucleic Acid Multiplex Assay Competition Analysis by Players
4.1 Global Nucleic Acid Multiplex Assay Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assay as of 2022)
4.3 Date of Key Players Enter into Nucleic Acid Multiplex Assay Market
4.4 Global Top Players Nucleic Acid Multiplex Assay Headquarters and Area Served
4.5 Key Players Nucleic Acid Multiplex Assay Product Solution and Service
4.6 Competitive Status
4.6.1 Nucleic Acid Multiplex Assay Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Luminex Corporation (US)
5.1.1 Luminex Corporation (US) Profile
5.1.2 Luminex Corporation (US) Main Business
5.1.3 Luminex Corporation (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.1.4 Luminex Corporation (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.1.5 Luminex Corporation (US) Recent Developments
5.2 Thermo Fisher Scientific Inc. (US)
5.2.1 Thermo Fisher Scientific Inc. (US) Profile
5.2.2 Thermo Fisher Scientific Inc. (US) Main Business
5.2.3 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Inc. (US) Recent Developments
5.3 Illumina, Inc (US)
5.3.1 Illumina, Inc (US) Profile
5.3.2 Illumina, Inc (US) Main Business
5.3.3 Illumina, Inc (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.3.4 Illumina, Inc (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.3.5 Bio-Rad Laboratories, Inc. (US) Recent Developments
5.4 Bio-Rad Laboratories, Inc. (US)
5.4.1 Bio-Rad Laboratories, Inc. (US) Profile
5.4.2 Bio-Rad Laboratories, Inc. (US) Main Business
5.4.3 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.4.4 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.4.5 Bio-Rad Laboratories, Inc. (US) Recent Developments
5.5 Qiagen N.V. (Netherlands)
5.5.1 Qiagen N.V. (Netherlands) Profile
5.5.2 Qiagen N.V. (Netherlands) Main Business
5.5.3 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.5.4 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.5.5 Qiagen N.V. (Netherlands) Recent Developments
5.6 Abcam plc (UK)
5.6.1 Abcam plc (UK) Profile
5.6.2 Abcam plc (UK) Main Business
5.6.3 Abcam plc (UK) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.6.4 Abcam plc (UK) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.6.5 Abcam plc (UK) Recent Developments
5.7 Becton, Dickinson and Company (US)
5.7.1 Becton, Dickinson and Company (US) Profile
5.7.2 Becton, Dickinson and Company (US) Main Business
5.7.3 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.7.4 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.7.5 Becton, Dickinson and Company (US) Recent Developments
5.8 Merck KGaA (Germany)
5.8.1 Merck KGaA (Germany) Profile
5.8.2 Merck KGaA (Germany) Main Business
5.8.3 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.8.4 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.8.5 Merck KGaA (Germany) Recent Developments
5.9 Agilent Technologies, Inc. (US)
5.9.1 Agilent Technologies, Inc. (US) Profile
5.9.2 Agilent Technologies, Inc. (US) Main Business
5.9.3 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.9.4 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.9.5 Agilent Technologies, Inc. (US) Recent Developments
5.10 Meso Scale Diagnostics (US)
5.10.1 Meso Scale Diagnostics (US) Profile
5.10.2 Meso Scale Diagnostics (US) Main Business
5.10.3 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.10.4 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.10.5 Meso Scale Diagnostics (US) Recent Developments
5.11 Randox Laboratories (UK)
5.11.1 Randox Laboratories (UK) Profile
5.11.2 Randox Laboratories (UK) Main Business
5.11.3 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.11.4 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.11.5 Randox Laboratories (UK) Recent Developments
5.12 Quanterix (US)
5.12.1 Quanterix (US) Profile
5.12.2 Quanterix (US) Main Business
5.12.3 Quanterix (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.12.4 Quanterix (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.12.5 Quanterix (US) Recent Developments
5.13 Bio-Techne Corporation (US)
5.13.1 Bio-Techne Corporation (US) Profile
5.13.2 Bio-Techne Corporation (US) Main Business
5.13.3 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.13.4 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.13.5 Bio-Techne Corporation (US) Recent Developments
5.14 Olink (Sweden)
5.14.1 Olink (Sweden) Profile
5.14.2 Olink (Sweden) Main Business
5.14.3 Olink (Sweden) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.14.4 Olink (Sweden) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.14.5 Olink (Sweden) Recent Developments
5.15 DiaSorin S.p.A. (Italy)
5.15.1 DiaSorin S.p.A. (Italy) Profile
5.15.2 DiaSorin S.p.A. (Italy) Main Business
5.15.3 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.15.4 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.15.5 DiaSorin S.p.A. (Italy) Recent Developments
5.16 Seegene (South Korea)
5.16.1 Seegene (South Korea) Profile
5.16.2 Seegene (South Korea) Main Business
5.16.3 Seegene (South Korea) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.16.4 Seegene (South Korea) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.16.5 Seegene (South Korea) Recent Developments
5.17 Promega Corporation (US)
5.17.1 Promega Corporation (US) Profile
5.17.2 Promega Corporation (US) Main Business
5.17.3 Promega Corporation (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.17.4 Promega Corporation (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.17.5 Promega Corporation (US) Recent Developments
5.18 Siemens Healthineers (Germany)
5.18.1 Siemens Healthineers (Germany) Profile
5.18.2 Siemens Healthineers (Germany) Main Business
5.18.3 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.18.4 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.18.5 Siemens Healthineers (Germany) Recent Developments
5.19 PerkinElmer, Inc. (US)
5.19.1 PerkinElmer, Inc. (US) Profile
5.19.2 PerkinElmer, Inc. (US) Main Business
5.19.3 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.19.4 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.19.5 PerkinElmer, Inc. (US) Recent Developments
5.20 Shimadzu Biotech (Japan)
5.20.1 Shimadzu Biotech (Japan) Profile
5.20.2 Shimadzu Biotech (Japan) Main Business
5.20.3 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.20.4 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.20.5 Shimadzu Biotech (Japan) Recent Developments
5.21 Antigenix America, Inc. (US)
5.21.1 Antigenix America, Inc. (US) Profile
5.21.2 Antigenix America, Inc. (US) Main Business
5.21.3 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.21.4 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.21.5 Antigenix America, Inc. (US) Recent Developments
5.22 Enzo Life Sciences, Inc. (US)
5.22.1 Enzo Life Sciences, Inc. (US) Profile
5.22.2 Enzo Life Sciences, Inc. (US) Main Business
5.22.3 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.22.4 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.22.5 Enzo Life Sciences, Inc. (US) Recent Developments
5.23 Boster Biological Technology (US)
5.23.1 Boster Biological Technology (US) Profile
5.23.2 Boster Biological Technology (US) Main Business
5.23.3 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.23.4 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.23.5 Boster Biological Technology (US) Recent Developments
5.24 AYOXXA Biosystems GmbH (Germany)
5.24.1 AYOXXA Biosystems GmbH (Germany) Profile
5.24.2 AYOXXA Biosystems GmbH (Germany) Main Business
5.24.3 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.24.4 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.24.5 AYOXXA Biosystems GmbH (Germany) Recent Developments
5.25 Cayman Chemical Company (US)
5.25.1 Cayman Chemical Company (US) Profile
5.25.2 Cayman Chemical Company (US) Main Business
5.25.3 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Products, Services and Solutions
5.25.4 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Revenue (US$ Million) & (2018-2023)
5.25.5 Cayman Chemical Company (US) Recent Developments
6 North America
6.1 North America Nucleic Acid Multiplex Assay Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Nucleic Acid Multiplex Assay Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nucleic Acid Multiplex Assay Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nucleic Acid Multiplex Assay Market Dynamics
11.1 Nucleic Acid Multiplex Assay Industry Trends
11.2 Nucleic Acid Multiplex Assay Market Drivers
11.3 Nucleic Acid Multiplex Assay Market Challenges
11.4 Nucleic Acid Multiplex Assay Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
